# Definium Therapeutics, Inc.: Form 8-K, filed Jun 16, 2023

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2023-06-16
- Accepted by EDGAR: Jun 16, 2023, 17:06 ET
- Period: 2023-06-16
- Accession: 0000950170-23-028678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/mnmd-20230616.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/mnmd-20230616.htm

Filed Jun 16, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-028678. Last ingested by Listed: Nov 10, 2026, 02:38 ET. No prices; not investment advice.